» Authors » J M Zozaya

J M Zozaya

Explore the profile of J M Zozaya including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 190
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Castan B, Borda F, Inarrairaegui M, Pastor G, Vila J, Zozaya J
Rev Esp Enferm Dig . 2002 Dec; 94(8):463-72. PMID: 12486851
Objectives: Digestive anisakiasis is a parasitic disease whose clinical manifestations depend on the effect of Anisakis simplex on the digestive tract wall. Larvae are acquired by eating raw or poorly...
22.
Borda F, Jimenez F, Vila J, Carral D, Zozaya J, Pastor G, et al.
Gastroenterol Hepatol . 2001 Jul; 24(6):292-6. PMID: 11459565
Objectives: Recent studies show that intravenous injection of somatostatin before endoscopic retrograde cholangiopancreatography (ERCP) is associated with a significant reduction in the rate of post-ERCP acute pancreatitis. The lack of...
23.
Elizalde I, Zozaya J, Valenti C, Rodriguez C, Borda F, Jimenez F
Rev Esp Enferm Dig . 1999 Aug; 91(6):457-9. PMID: 10431095
No abstract available.
24.
Fernandez-Rodriguez C, Prieto J, Quiroga J, Zozaya J, Andrade A, Rodriguez-Ortigosa C
Dig Dis Sci . 1997 Jul; 42(7):1416-20. PMID: 9246039
Cyclic guanosine monophosphate (cGMP) has been proposed to mediate peripheral arterial vasodilation in liver cirrhosis. Nitric oxide and natriuretic peptides are the main signals for cGMP generation. Variation in urinary...
25.
Aliaga L, Mediavilla J, Omar M, Zozaya J, Prieto J
Presse Med . 1995 Apr; 24(16):758-62. PMID: 7784414
Objectives: We have studied the vascular resistance at the posterior tibial artery utilizing the Doppler reverse/forward flow ratio, and its relationship to systemic vascular resistance and renal function in 32...
26.
Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Zozaya J, et al.
Hepatology . 1995 Apr; 21(4):986-94. PMID: 7705810
Seventeen cirrhotics with refractory ascites were treated with transjugular intrahepatic portosystemic shunt (TIPS) and followed for 15.5 +/- 3.4 months. Five patients died, four within 3 months after TIPS (hepatocellular...
27.
Fernandez-Rodriguez C, Prieto J, Quiroga J, Zozaya J, Andrade A, Rodriguez-Martinez D
J Hepatol . 1994 Aug; 21(2):211-6. PMID: 7989711
Plasma atrial natriuretic factor concentrations and different hemodynamic parameters, including the evaluation of femoral arteriovenous shunting by measuring the arteriovenous difference of oxygen content (Ca-vO2), were determined in eight healthy...
28.
Echarri A, Borda F, Jimenez F, Jimenez E, Vidan J, Zozaya J
Rev Esp Enferm Dig . 1994 Apr; 85(4):243-7. PMID: 8031611
We study the diagnostic value of some macroscopic features which might be considered suspicious of lymphoma (RESL): thickened gastric folds, diffuse involvement, shallow star shaped ulcers, net lesion limits, size...
29.
Rousseau H, Vinel J, Bilbao J, Longo J, Maquin P, Zozaya J, et al.
Cardiovasc Intervent Radiol . 1994 Jan; 17(1):7-11. PMID: 8187135
Purpose: The aim of the present study was to assess the efficacy of transjugular intrahepatic portosystemic shunts (TIPS) in 45 patients with cirrhosis during a mean follow-up of 7 months....
30.
Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, et al.
Hepatology . 1993 Aug; 18(2):309-14. PMID: 8340060
Hypersplenism is of great relevance in the management of cirrhosis because of the widespread use of myelodepressant drugs such as interferon or antineoplastic agents. Because no standard therapy exists for...